insights_auto
Why is DC4 up 2.38%?
Dive Deeperchevron_right
DC4:FRA
DexCom Inc
€77.40
arrow_upward
+2.38%(+1.80) 1D
Oct 5, 10:00:00 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DC4...
Open
€75.80
High
€77.40
Low
€75.80
Mkt. cap
32.79B
Avg. vol.
57.00
Volume
0.00
52-wk high
€79.20
52-wk low
€46.88
No. of employees
11K
Open
€75.80
High
€77.40
Low
€75.80
Mkt. cap
32.79B
Avg. vol.
57.00
Volume
0.00
52-wk high
€79.20
52-wk low
€46.88
No. of employees
11K
News stories
From web sources and news partners
AD HOC NEWS
·
6 hours ago
DexCom stock gains 1.22 percent ahead of October earnings
AD HOC NEWS
·
1 day ago
Dexcom stock fell 1.01 percent as RBC lifted its target
AD HOC NEWS
·
1 day ago
Dexcom announces Type 2 report as Dexcom stock costs EUR 76.20
Zacks Investment Research
·
3 days ago
DXCM Report Highlights CGM Growth Opportunity in Type 2 Diabetes Care
Profile
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland. Wikipedia
About DexCom Inc
CEO-
Employees11K
Founded1999
HeadquartersSan Diego, California, United States
SectorMedical device
Websitedexcom.com